表紙
市場調查報告書

顯影劑的全球市場 - 至2024年的預測:碘、釓、鋇、微泡沫

Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 259150
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
顯影劑的全球市場 - 至2024年的預測:碘、釓、鋇、微泡沫 Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024
出版日期: 2019年12月11日內容資訊: 英文 161 Pages
簡介

全球顯影劑市場預測將從2019年的50億美元到2024年達60億美元,在預測期間中預計將以3.8%的年複合成長率 (CAGR) 成長。該市場的成長,主要起因於對顯影劑的認證數的增加及全球性CT、MRI檢驗數的增加。

本報告提供全球顯影劑市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 顯影劑:市場概要
  • 歐洲的顯影劑市場:各種模式
  • 顯影劑市場佔有率:各種模式
  • 顯影劑市場佔有率:各給藥途徑
  • 顯影劑市場佔有率:各適應症
  • 顯影劑市場佔有率:各用途
  • 顯影劑市場佔有率:各類型
  • 顯影劑市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第6章 顯影劑市場:各類型

  • 簡介
  • 碘顯影劑
  • 釓顯影劑
  • 微泡沫顯影劑
  • 鋇顯影劑

第7章 顯影劑的全球市場:各種模式

  • 簡介
  • X光/CT
  • MRI
  • 超音波

第8章 顯影劑的全球市場:各適應症

  • 簡介
  • 心血管疾病
  • 癌症
  • 腸胃疾病
  • 肌肉骨骼系統疾病
  • 神經疾病
  • 腎臟疾病

第9章 顯影劑的全球市場:各給藥途徑

  • 簡介
  • 血管內
  • 口服
  • 直腸
  • 其他

第10章 顯影劑的全球市場:各用途

  • 簡介
  • 放射線科
  • IVR
  • IVC

第11章 顯影劑的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 簡介
  • 市場佔有率分析
  • RIGHT-TO-WIN
  • 競爭領導製圖
  • 競爭模式

第13章 企業簡介

  • GE HEALTHCARE
  • BRACCO IMAGING
  • BAYER
  • GUERBET GROUP
  • LANTHEUS MEDICAL IMAGING, INC.
  • 第一三共
  • UNIJULES LIFE SCIENCES
  • J.B. CHEMICALS AND PHARMACEUTICALS LTD.
  • SANOCHEMIA
  • MAGNUS HEALTH
  • TAEJOON PHARM
  • JODAS EXPOIM
  • NANO THERAPEUTICS PVT. LTD.
  • KIRAN X-RAY
  • INTERPHARMA PRAHA A.S.
  • IMAX DIAGNOSTIC IMAGING LIMITED
  • YANGTZE RIVER PHARMACEUTICAL GROUP (YRPG)
  • SPAGO NANOMEDICAL AB
  • SUBHRA PHARMA PVT. LTD.
  • M. BIOTECH LIMITED
  • MRI顯影劑:產品比較
  • CT顯影劑:產品比較
  • 超音波顯影劑:產品比較

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3577

"Contrast media/contrast agents market is projected to grow at a CAGR of 3.8%."

The global contrast media/contrast agents market is projected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide.

Growth in the market can primarily be attributed to factors such as the increasing number of approvals for contrast agents and the rising volume of CT and MRI examinations globally. The growing number of research & funding activities for contrast agents and their applications provide immense opportunities for players in the contrast media market.

"The X-ray/CT procedures segment to hold the largest contrast media market share in 2019."

Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

"The cardiovascular disorders segment is projected to grow at the highest CAGR during the forecast period."

Based on the indication, the contrast media market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

"Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019-2024. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the contrast media market in this region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
  • By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
  • By Region: North America: 38%, Europe: 23%, Asia Pacific : 29%, RoW: 10%

GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany),Guerbet (France), Lantheus (US) were the leading players in the contrast media market.

Research Coverage:

This report studies the Contrast Media/Contrast Agents market based on product, application, modality, indication, route of administration and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the Contrast Media/Contrast Agents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the contrast media market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • 2.1.1.1 Secondary research
      • 2.1.1.2 Primary research
    • 2.1.2 KEY INSIGHTS FROM PRIMARY SOURCES
    • 2.1.3 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.1.4 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.1.5 MARKET DATA VALIDATION AND TRIANGULATION
  • 2.2 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CONTRAST MEDIA MARKET OVERVIEW
  • 4.2 EUROPEAN CONTRAST MEDIA MARKET, BY MODALITY (2019)
  • 4.3 CONTRAST MEDIA MARKET SHARE, BY MODALITY, 2019 VS. 2024
  • 4.4 CONTRAST MEDIA MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2019 VS. 2024
  • 4.5 CONTRAST MEDIA MARKET SHARE, BY INDICATION, 2019 VS. 2024
  • 4.6 CONTRAST MEDIA MARKET SHARE, BY APPLICATION, 2019 VS. 2024
  • 4.7 CONTRAST MEDIA MARKET SHARE, BY TYPE, 2019 VS. 2024
  • 4.8 GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of cancer and CVDs
      • 5.2.1.2 Approvals of contrast agents
      • 5.2.1.3 Increasing demand for early diagnosis and rising volume of CT and MRI examinations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Side-effects and allergic reactions associated with contrast agents
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Generic contrast media
      • 5.2.3.2 Increasing research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technological advancements in imaging solutions
      • 5.2.4.2 Restriction and withdrawal of linear gadolinium-based contrast agents

6 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 IODINATED CONTRAST MEDIA
    • 6.2.1 EXTENSIVE USAGE OF IODINATED CONTRAST MEDIA IN CT EXAMINATIONS IS A KEY FACTOR SUPPORTING MARKET GROWTH
  • 6.3 GADOLINIUM-BASED CONTRAST MEDIA
    • 6.3.1 APAC IS THE FASTEST-GROWING MARKET FOR GADOLINIUM-BASED CONTRAST MEDIA
  • 6.4 MICROBUBBLE CONTRAST MEDIA
    • 6.4.1 MICROBUBBLE CONTRAST MEDIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 6.5 BARIUM-BASED CONTRAST MEDIA
    • 6.5.1 BARIUM-BASED CONTRAST MEDIA CAN CAUSE ADVERSE EFFECTS IN PATIENTS, OWING TO WHICH THE MARKET IS PROJECTED TO DECLINE

7 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

  • 7.1 INTRODUCTION
  • 7.2 X-RAY/CT
    • 7.2.1 X-RAY/CT ACCOUNTS FOR THE LARGEST SHARE OF THE CONTRAST MEDIA MARKET
  • 7.3 MAGNETIC RESONANCE IMAGING
    • 7.3.1 GROWING NUMBER OF MRI SCANNERS AND INCREASING MRI EXAMINATIONS ARE LIKELY TO DRIVE MARKET GROWTH
  • 7.4 ULTRASOUND
    • 7.4.1 ULTRASOUND CONTRAST AGENTS WILL REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

8 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION

  • 8.1 INTRODUCTION
  • 8.2 CARDIOVASCULAR DISEASES
    • 8.2.1 CARDIOVASCULAR DISEASES SEGMENT TO DOMINATE THE CONTRAST MEDIA MARKET
  • 8.3 CANCER
    • 8.3.1 ASIA PACIFIC IS EXPECTED TO REGISTER RELATIVELY HIGHER GROWTH OWING TO THE HIGH CANCER PREVALENCE IN THE REGION
  • 8.4 GASTROINTESTINAL DISORDERS
    • 8.4.1 RISING PREVALENCE OF GI DISORDERS TO SUPPORT MARKET GROWTH
  • 8.5 MUSCULOSKELETAL DISORDERS
    • 8.5.1 RISING INCIDENCE OF WORK-RELATED MUSCULOSKELETAL DISORDERS TO SUPPORT MARKET GROWTH
  • 8.6 NEUROLOGICAL DISORDERS
    • 8.6.1 RISING PREVALENCE OF DEMENTIA WORLDWIDE TO SUPPORT MARKET GROWTH
  • 8.7 NEPHROLOGICAL DISORDERS
    • 8.7.1 RISING PREVALENCE OF ESRD IS DRIVING THE DEMAND FOR DIAGNOSTIC TOOLS FOR KIDNEY DISEASES

9 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION

  • 9.1 INTRODUCTION
  • 9.2 INTRAVASCULAR ROUTE
    • 9.2.1 INTRAVASCULAR ROUTE OF ADMINISTRATION IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
      • 9.2.1.1 INTRAVENOUS (IV)
      • 9.2.1.2 INTRA-ARTERIAL (IA)
  • 9.3 ORAL ROUTE
    • 9.3.1 NORTH AMERICA TO DOMINATE THE CONTRAST MEDIA MARKET FOR ORAL ROUTE OF ADMINISTRATION
  • 9.4 RECTAL ROUTE
    • 9.4.1 CONTRAST AGENTS ADMINISTERED RECTALLY ARE LIQUID E-Z-PAQUE, LIQUID POLIBAR PLUS, AND MICROPAQUE
  • 9.5 OTHER ROUTES OF ADMINISTRATION

10 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 RADIOLOGY
    • 10.2.1 GROWING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE CONTRAST MEDIA MARKET FOR RADIOLOGY APPLICATIONS
  • 10.3 INTERVENTIONAL RADIOLOGY
    • 10.3.1 INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
  • 10.4 INTERVENTIONAL CARDIOLOGY
    • 10.4.1 RISING INCIDENCE OF CARDIAC DISORDERS TO DRIVE THE DEMAND FOR INTERVENTIONAL CARDIOLOGY PROCEDURES

11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 The US dominates the global contrast media market
    • 11.2.2 CANADA
      • 11.2.2.1 Increasing investments in improving medical imaging-a major factor driving market growth in Canada
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Presence of a well-developed diagnostic imaging infrastructure is a major factor supporting market growth in Germany
    • 11.3.2 FRANCE
      • 11.3.2.1 Increasing prevalence of cancer will drive the market for contrast media in France
    • 11.3.3 UK
      • 11.3.3.1 Increasing investments in the field of diagnostic imaging to boost market growth
    • 11.3.4 ITALY
      • 11.3.4.1 Growing prevalence of cancer and obesity will drive the demand for diagnostic procedures in Italy
    • 11.3.5 SPAIN
      • 11.3.5.1 Shortage of radiologists in the country to restrain market growth
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 JAPAN
      • 11.4.1.1 Japan dominates the APAC contrast media market
    • 11.4.2 CHINA
      • 11.4.2.1 High incidence of cancer and strokes will support the market for contrast media in China
    • 11.4.3 INDIA
      • 11.4.3.1 Growing investments in the Indian radiology market will propel market growth
    • 11.4.4 REST OF ASIA PACIFIC
  • 11.5 REST OF THE WORLD

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS
  • 12.3 RIGHT-TO-WIN
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 VISIONARY LEADERS
    • 12.4.2 INNOVATORS
    • 12.4.3 DYNAMIC DIFFERENTIATORS
    • 12.4.4 EMERGING COMPANIES
  • 12.5 COMPETITIVE SCENARIO
    • 12.5.1 PRODUCT LAUNCHES & APPROVALS
    • 12.5.2 EXPANSIONS
    • 12.5.3 ACQUISITIONS
    • 12.5.4 PARTNERSHIPS & AGREEMENTS

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)*

  • 13.1 GE HEALTHCARE
  • 13.2 BRACCO IMAGING S.P.A
  • 13.3 BAYER AG
  • 13.4 GUERBET GROUP
  • 13.5 LANTHEUS MEDICAL IMAGING, INC.
  • 13.6 DAIICHI SANKYO
  • 13.7 UNIJULES LIFE SCIENCES
  • 13.8 J.B. CHEMICALS AND PHARMACEUTICALS LTD.
  • 13.9 SANOCHEMIA
  • 13.10 MAGNUS HEALTH
  • 13.11 TAEJOON PHARM
  • 13.12 JODAS EXPOIM
  • 13.13 NANO THERAPEUTICS PVT. LTD.
  • 13.14 KIRAN X-RAY
  • 13.15 INTERPHARMA PRAHA A.S.
  • 13.16 IMAX DIAGNOSTIC IMAGING LIMITED
  • 13.17 YANGTZE RIVER PHARMACEUTICAL GROUP (YRPG)
  • 13.18 SPAGO NANOMEDICAL AB
  • 13.19 SUBHRA PHARMA PVT. LTD.
  • 13.20 M. BIOTECH LIMITED
  • 13.21 MRI CONTRAST AGENTS: PRODUCT COMPARISON
  • 13.22 CT CONTRAST AGENTS: PRODUCT COMPARISON
  • 13.23 ULTRASOUND CONTRAST AGENTS: PRODUCT COMPARISON

Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 AVAILABLE CUSTOMIZATIONS
  • 14.3 RELATED REPORTS
  • 14.4 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: LIST OF SIDE-EFFECTS/REACTIONS TO CONTRAST MEDIA, BY TYPE
  • TABLE 2: INDICATIVE LIST OF RESEARCH STUDIES
  • TABLE 3: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: IODINATED CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 9: INSTALLED BASE OF CT SCANNERS, BY REGION, 2017 VS. 2018
  • TABLE 10: INCREASE IN CT PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION)
  • TABLE 11: X-RAY/CT CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: INSTALLED BASE OF MRI SYSTEMS, BY REGION, 2017 VS. 2018
  • TABLE 13: INCREASE IN MRI PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION)
  • TABLE 14: MRI CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: ULTRASOUND CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 17: CONTRAST MEDIA MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: CONTRAST MEDIA MARKET FOR CANCER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: CONTRAST MEDIA MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: CONTRAST MEDIA MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: CONTRAST MEDIA MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CONTRAST MEDIA MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 24: CONTRAST MEDIA MARKET FOR INTRAVASCULAR ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: CONTRAST MEDIA MARKET FOR ORAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: CONTRAST MEDIA MARKET FOR RECTAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: CONTRAST MEDIA MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 29: CONTRAST MEDIA MARKET FOR RADIOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: CONTRAST MEDIA MARKET FOR INTERVENTIONAL RADIOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: CONTRAST MEDIA MARKET FOR INTERVENTIONAL CARDIOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: CONTRAST-ENHANCED CT PROCEDURAL VOLUME, BY REGION, 2017 VS. 2018 (MILLION)
  • TABLE 33: CONTRAST-ENHANCED MRI PROCEDURAL VOLUME, BY REGION, 2017 VS. 2018 (MILLION)
  • TABLE 34: CONTRAST MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CONTRAST MEDIA MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: US: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 42: US: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: US: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 44: US: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 45: US: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 46: CANADA: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 47: CANADA: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: CANADA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 49: CANADA: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 50: CANADA: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: EUROPE: CONTRAST MEDIA MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: EUROPE: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 53: EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 55: EUROPE: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 56: EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: GERMANY: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 58: GERMANY: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: GERMANY: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 60: GERMANY: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 61: GERMANY: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 62: FRANCE: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 63: FRANCE: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64: FRANCE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 65: FRANCE: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 66: FRANCE: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: UK: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 68: UK: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: UK: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 70: UK: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 71: UK: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 72: ITALY: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 73: ITALY: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: ITALY: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 75: ITALY: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 76: ITALY: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 77: SPAIN: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 78: SPAIN: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: SPAIN: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 80: SPAIN: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 81: SPAIN: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 82: ROE: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 83: ROE: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: ROE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 85: ROE: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 86: ROE: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 87: APAC: CONTRAST MEDIA MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 88: APAC: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 89: APAC: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: APAC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 91: APAC: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 92: APAC: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 93: JAPAN: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 94: JAPAN: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: JAPAN: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 96: JAPAN: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 97: JAPAN: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 98: CHINA: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 99: CHINA: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: CHINA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 101: CHINA: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 102: CHINA: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 103: INDIA: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 104: INDIA: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: INDIA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 106: INDIA: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 107: INDIA: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 108: ROAPAC: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 109: ROAPAC: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: ROAPAC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 111: ROAPAC: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 112: ROAPAC: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 113: ROW: CONTRAST MEDIA MARKET, BY MODALITY, 2017-2024 (USD MILLION)
  • TABLE 114: ROW: CONTRAST MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: ROW: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 116: ROW: CONTRAST MEDIA MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 117: ROW: CONTRAST MEDIA MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 118: PRODUCT LAUNCHES & APPROVALS (2016-2019)
  • TABLE 119: EXPANSIONS (2016-2019)
  • TABLE 120: ACQUISITIONS (2016-2019)
  • TABLE 121: PARTNERSHIPS & AGREEMENTS (2016-2019)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY STEPS: CONTRAST MEDIA MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 6: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: CONTRAST MEDIA MARKET, BY MODALITY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: CONTRAST MEDIA MARKET, BY INDICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: CONTRAST MEDIA MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: CONTRAST MEDIA MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 13: ASIA PACIFIC IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE CONTRAST MEDIA MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: GROWING VOLUME OF CT AND MRI EXAMINATIONS WILL DRIVE THE GROWTH OF THE CONTRAST MEDIA MARKET
  • FIGURE 15: GERMANY ACCOUNTS FOR THE LARGEST SHARE OF THE CONTRAST MEDIA MARKET IN EUROPE
  • FIGURE 16: X-RAY/CT WILL CONTINUE TO DOMINATE THE CONTRAST MEDIA MARKET, BY MODALITY, IN 2024
  • FIGURE 17: INTRAVASCULAR ROUTE ACCOUNTS FOR THE LARGEST SHARE OF THE MARKET
  • FIGURE 18: CARDIOVASCULAR DISEASES TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA MARKET IN 2024
  • FIGURE 19: RADIOLOGY COMMANDS THE LARGEST SHARE OF THE CONTRAST MEDIA MARKET
  • FIGURE 20: IODINATED CONTRAST MEDIA ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA MARKET, BY TYPE
  • FIGURE 21: APAC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22: CONTRAST MEDIA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23: NORTH AMERICA WILL CONTINUE TO DOMINATE THE CONTRAST MEDIA MARKET IN 2024
  • FIGURE 24: NORTH AMERICA: CONTRAST MEDIA MARKET SNAPSHOT
  • FIGURE 25: ASIA PACIFIC: CONTRAST MEDIA MARKET SNAPSHOT
  • FIGURE 26: KEY DEVELOPMENTS IN THE CONTRAST MEDIA MARKET, 2016-2019
  • FIGURE 27: CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 28: CONTRAST MEDIA MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 29: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 30: BRACCO IMAGING S.P.A: COMPANY SNAPSHOT (2018)
  • FIGURE 31: BAYER AG: COMPANY SNAPSHOT (2018)
  • FIGURE 32: GUERBET GROUP: COMPANY SNAPSHOT (2018) 130  
  • FIGURE 33: LANTHEUS: COMPANY SNAPSHOT (2018)
  • FIGURE 34: DAIICHI SANKYO: COMPANY SNAPSHOT (2018)
  • FIGURE 35: J.B. CHEMICALS & PHARMACEUTICALS: COMPANY SNAPSHOT (2018)
  • FIGURE 36: SANOCHEMIA: COMPANY SNAPSHOT (2018)